{"sourcedb":"DevicePMAs@therightstef","sourceid":"P030056_S008","text":"Approval for the claim to test a pediatric population with the fda approved advia centaur hcv readypack reagents and advia centaur hcv quality control materials. the device, as modified, will be marketed under the trade name advia centaur hcv readypack reagents and advia centaur hcv quality control materials and is indicated for: advia centaur and advia centaur xp systems.  The advia centaur hcv (ahcv) assay is an in vitro diagnostic immunoassay for the qualitative determination of immunoglobulin g (igg) antibodies to hepatitis c virus (hcv) in human pediatric (18 months  21 years) and adult serum and plasma (edta, lithium or sodium heparinized) using the advia centaur and advia centaur xp systems. the assay may be used in conjunction with other serological and clinical information to aid in the diagnosis of individuals with symptoms of hepatitis and in individuals at risk for hepatitis c infection. advia centaur cp system:  the advia centaur hcv (ahcv) assay is an in vitro diagnostic immunoassay for the qualitative determination of immunoglobulin g (igg) antibodies to hepatitis c virus (hcv) in human pediatric (18 months  21 years) and adult serum and plasma (edta, lithium or sodium heparinized) using the advia centaur cp system. the assay may be used in conjunction with other serological and clinical information to aid in the diagnosis of individuals with symptoms of hepatitis and in individuals at risk for hepatitis c infection.","project":"consensus_PMA_Age_Indications"}